Radical cystectomy in patients aged < 80 years versus ≥ 80 years: analysis of preoperative geriatric assessment scores in predicting postoperative morbidity and mortality
- PMID: 39347804
- PMCID: PMC11442567
- DOI: 10.1007/s00345-024-05248-y
Radical cystectomy in patients aged < 80 years versus ≥ 80 years: analysis of preoperative geriatric assessment scores in predicting postoperative morbidity and mortality
Abstract
Purpose: Pre-operative assessment of surgical risk is essential for patient counselling in the elderly patient population. Our purpose was to compare validated geriatric assessment scores (GAS) in predicting postoperative morbidity and mortality in patients ≥ 80 years.
Methods: Overall, eight preoperative GAS were assessed for each patient who received RC from 2016 to 2021. Postoperative morbidity was recorded according to the Clavien-Dindo classification (CDC) of surgical complications. Binary logistic regression analyses were used to determine prediction of 30-d morbidity and 90-d mortality in patients ≥ 80 years.
Results: In total, 424 patients were analysed (77.4% male) with median age of 71 years (IQR: 68.82;70.69), of which 67 (15.8%) were ≥ 80 years. Patients age ≥ 80 years showed more 30-d CDC grade ≥ IIIb (41.07% vs. 27.74% compared to < 80 years, p < .001) and worse 90-d mortality (26.87% vs. 4.76%, p < .001). In patients ≥ 80 years, morbidity was predicted by simplified Frailty Index (sFI) ≥ 2 (OR: 2.06, 95% CI: 1.27-3.34, p = .004), Eastern Cooperative Oncology Group (ECOG) performance status ≥ 2 (OR: 2.78, 95% CI: 1.18-6.54, p = .019) and severe Adult Comorbidity Evaluation (ACE)-27 score (OR: 2.07, 95% CI: 1.13-3.79, p = .019), while 90-d mortality was predicted by CDC grade ≥ IIIb (OR: 22.91, 95% CI: 8.74-60.09, p < .001) and ECOG ≥ 2 (OR: 2.87, 95% CI: 1.05-7.86, p = .04).
Conclusion: Even in a high-volume center of RC, 90-d mortality is significantly higher in patients age ≥ 80. Our results suggest in patient age ≥ 80, sFI ≥ 2, ECOG performance status ≥ 2 and severe ACE-27 score as clinical cut-off value to evaluate alternative bladder-sparing concepts.
Keywords: Comorbidities; Geriatric assessment; Morbidity; Mortality; Outcome improvement; Postoperative complications; Radical cystectomy.
© 2024. The Author(s).
Conflict of interest statement
All other authors have nothing to declare.
References
-
- Cathomas R, Lorch A, Bruins HM, Compérat EM, Cowan NC, Efstathiou JA et al (2022) The 2021 updated european association of urology guidelines on metastatic urothelial carcinoma. Eur Urol 81:95–103 - PubMed
-
- Mitra AP, Cai J, Miranda G, Bhanvadia S, Quinn DI, Schuckman AK et al (2022) Management trends and outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder: evolution of the University of Southern California experience over 3,347 cases. J Urol 207:302–313 - PMC - PubMed
-
- Daneshmand S, Ahmadi H, Schuckman AK, Mitra AP, Cai J, Miranda G et al (2014) Enhanced recovery protocol after radical cystectomy for bladder cancer. J Urol 192:50–55 - PubMed
-
- Parekh DJ, Reis IM, Castle EP, Gonzalgo ML, Woods ME, Svatek RS et al (2018) Robot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial. Lancet 391:2525–2536 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources